150 related articles for article (PubMed ID: 29695230)
1. Incisional hernia and its impact on health-related quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a national prospective cohort study.
Ravn S; Thaysen HV; Harsløf S; Sørensen MM; Iversen LH
World J Surg Oncol; 2018 Apr; 16(1):85. PubMed ID: 29695230
[TBL] [Abstract][Full Text] [Related]
2. Incidence and predictors of incisional hernia after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Tuttle TM; Huang JL; Kizy S; Altman AM; Nalluri H; Marmor S; Gaertner WB; Jensen EH; Hui JYC
Int J Hyperthermia; 2019; 36(1):812-816. PubMed ID: 31451032
[No Abstract] [Full Text] [Related]
3. Incidence of incisional hernia in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: an observational clinical study from a tertiary oncology referral care center in India.
Ray M; Kumar A; Maranna H
World J Surg Oncol; 2024 May; 22(1):132. PubMed ID: 38760663
[TBL] [Abstract][Full Text] [Related]
4. Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy.
Canda AE; Arslan C; Terzi C; Sokmen S; Yavuzsen T; Ozkardesler S; Unlu M; Obuz F; Fuzun M
World J Surg Oncol; 2018 Mar; 16(1):70. PubMed ID: 29587771
[TBL] [Abstract][Full Text] [Related]
5. Long-term Quality of Life After Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei: A Prospective Longitudinal Study.
Stearns AT; Malcomson L; Punnett G; Abudeeb H; Aziz O; Selvasekar CR; Fulford PE; Wilson MS; Renehan AG; O'Dwyer ST
Ann Surg Oncol; 2018 Apr; 25(4):965-973. PubMed ID: 29313146
[TBL] [Abstract][Full Text] [Related]
6. Enterocutaneous fistula in patients with peritoneal malignancy following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Incidence, management and outcomes.
Valle SJ; Alzahrani N; Alzahrani S; Traiki TB; Liauw W; Morris DL
Surg Oncol; 2016 Sep; 25(3):315-20. PubMed ID: 27566038
[TBL] [Abstract][Full Text] [Related]
7. Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis.
Vassos N; Förtsch T; Aladashvili A; Hohenberger W; Croner RS
World J Surg Oncol; 2016 Feb; 14(1):42. PubMed ID: 26912149
[TBL] [Abstract][Full Text] [Related]
8. Increased risk for incisional hernia following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
Ben-Yaacov A; Laks S; Zoabi G; Kirshenboim Z; Goldenshlger A; Hazzan D; Westrich G; Owda Y; Segev L; Nissan A; Goldenshluger M
ANZ J Surg; 2023 Sep; 93(9):2192-2196. PubMed ID: 37431168
[TBL] [Abstract][Full Text] [Related]
9. Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.
Berger Y; Aycart S; Mandeli JP; Heskel M; Sarpel U; Labow DM
Surg Oncol; 2015 Sep; 24(3):264-9. PubMed ID: 26143715
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Early Recurrence on Quality of Life after Cytoreduction with HIPEC.
Hinkle NM; Botta V; Sharpe JP; Dickson P; Deneve J; Munene G
Am Surg; 2017 Jun; 83(6):633-639. PubMed ID: 28637567
[TBL] [Abstract][Full Text] [Related]
11. Incisional hernias post cytoreductive surgery/peritonectomy and hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis.
Mac Curtain BM; Qian W; Temperley HC; Simpkin AJ; Ng ZQ
Hernia; 2023 Oct; 27(5):1067-1083. PubMed ID: 37653188
[TBL] [Abstract][Full Text] [Related]
12. Cirrhosis is not a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in highly selected patients.
Weiss A; Ward EP; Baumgartner JM; Lowy AM; Kelly KJ
World J Surg Oncol; 2018 Apr; 16(1):87. PubMed ID: 29699564
[TBL] [Abstract][Full Text] [Related]
13. A Novel Tool for Predicting Major Complications After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
Baumgartner JM; Kwong TG; Ma GL; Messer K; Kelly KJ; Lowy AM
Ann Surg Oncol; 2016 May; 23(5):1609-17. PubMed ID: 26678406
[TBL] [Abstract][Full Text] [Related]
14. Cytoreduction with hyperthermic intraperitoneal chemotherapy: an appraisal of outcomes and cost at a newly established peritoneal malignancy program.
Hinkle NM; MacDonald J; Sharpe JP; Dickson P; Deneve J; Munene G
Am J Surg; 2016 Sep; 212(3):413-8. PubMed ID: 27086201
[TBL] [Abstract][Full Text] [Related]
15. Hyperthermic intraperitoneal chemotherapy plus simultaneous versus staged cytoreductive surgery for gastric cancer with occult peritoneal metastasis.
Wu X; Li Z; Li Z; Jia Y; Shan F; Ji X; Bu Z; Zhang L; Wu A; Ji J
J Surg Oncol; 2015 Jun; 111(7):840-7. PubMed ID: 25864884
[TBL] [Abstract][Full Text] [Related]
16. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies.
Wu HT; Yang XJ; Huang CQ; Sun JH; Ji ZH; Peng KW; Zhang Q; Li Y
World J Surg Oncol; 2016 Sep; 14(1):246. PubMed ID: 27633880
[TBL] [Abstract][Full Text] [Related]
17. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Dissemination from Small Bowel Malignancy: Results from a Single Specialized Center.
Liu Y; Ishibashi H; Takeshita K; Mizumoto A; Hirano M; Sako S; Takegawa S; Takao N; Ichinose M; Yonemura Y
Ann Surg Oncol; 2016 May; 23(5):1625-31. PubMed ID: 26717938
[TBL] [Abstract][Full Text] [Related]
18. Abdominal Wall Morbidity Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Struller F; Koenigsrainer I; Horvath P; Koenigsrainer A; Beckert S
Scand J Surg; 2017 Dec; 106(4):294-298. PubMed ID: 28737098
[TBL] [Abstract][Full Text] [Related]
19. Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups.
Amblard I; Mercier F; Bartlett DL; Ahrendt SA; Lee KW; Zeh HJ; Levine EA; Baratti D; Deraco M; Piso P; Morris DL; Rau B; Tentes AAK; Tuech JJ; Quenet F; Akaishi E; Pocard M; Yonemura Y; Lorimier G; Delroeux D; Villeneuve L; Glehen O; Passot G;
Eur J Surg Oncol; 2018 Sep; 44(9):1378-1383. PubMed ID: 30131104
[TBL] [Abstract][Full Text] [Related]
20. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
